Should You Accumulate Immunic Inc (IMUX) Stock Thursday Morning?

Immunic Inc (IMUX) has risen Thursday morning, with the stock increasing 1.72% in pre-market trading to 1.18. IMUX's short-term technical score of 54 indicates that the stock has traded more bullishly over the last month than 54% of stocks on the market. In the Biotechnology industry, which ranks 128 out of 146 industries, the stock ranks higher than 67% of stocks. Immunic Inc has fallen 18.88% over the past month, closing at $1.51 on November 10. During this period of time, the stock fell as low as $1.16 and as high as $1.62. IMUX has an average analyst recommendation of Strong Buy. The company has an average price target of $23.86.

IMUX has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on IMUX!

See Full IMUX Report

Immunic Inc has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Biotechnology industry which is number 129 by this metric, IMUX ranks better than 129% of stocks.

Important Dates for Investors in IMUX:

-Immunic Inc is set to release earnings on 2/1/2023. Over the last 12 months, the company has reported EPS of $-2.75. -We do not have a set dividend date for Immunic Inc at this time. Click Here To Get The Full Report on Immunic Inc (IMUX)